175 related articles for article (PubMed ID: 7878915)
1. Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation.
Hess AD; Fischer AC; Horwitz LR; Bright EC; Hess JM
Transplant Proc; 1995 Feb; 27(1):1370-3. PubMed ID: 7878915
[No Abstract] [Full Text] [Related]
2. Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation.
Heath WR; Miller JF; Sprent J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1222-4. PubMed ID: 8442095
[No Abstract] [Full Text] [Related]
3. Selective inhibition of CD4 graft-versus-host activity in IL-2-treated mice.
Sykes M; Abraham VS; Harty MW; Pearson DA
Transplant Proc; 1993 Feb; 25(1 Pt 2):1225-6. PubMed ID: 8442096
[No Abstract] [Full Text] [Related]
4. Peripheral tolerance specific for host minor histocompatibility antigens in acute GVHR-protected mice is associated with functional deletion of CD4+ but not CD8+ T cells and an active suppressive mechanism.
Miconnet I; Bruley-Rosset M; Halle-Pannenko O
Transplant Proc; 1993 Feb; 25(1 Pt 1):327-8. PubMed ID: 8438320
[No Abstract] [Full Text] [Related]
5. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
Hess AD; Horwitz LR; Laulis MK
Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
[No Abstract] [Full Text] [Related]
6. Induction of antigen-specific tolerance: antigen form and injection route.
Yoshimura N; Hamashima T; Oka T
Transplant Proc; 1996 Jun; 28(3):1150-1. PubMed ID: 8658604
[No Abstract] [Full Text] [Related]
7. UVB-irradiated bone marrow allografts in rats: induction of unresponsiveness for long-term heart allografts without GVHD.
Wasfie T; Chabot J; Pepino P; Tezuka K; Hardy MA
Transplant Proc; 1990 Aug; 22(4):2011-2. PubMed ID: 2389512
[No Abstract] [Full Text] [Related]
8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
9. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine-induced autoimmunity: critical role of autoregulation in the prevention of major histocompatibility class II-dependent autoaggression.
Hess AD; Fischer AC; Horwitz LR; Laulis MK
Transplant Proc; 1993 Oct; 25(5):2811-3. PubMed ID: 8212244
[No Abstract] [Full Text] [Related]
11. Tolerance in Mlsa mismatched chimeras prepared with allogeneic bone marrow alone or in combination with syngeneic bone marrow.
Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
Transplant Proc; 1999; 31(1-2):702-3. PubMed ID: 10083303
[No Abstract] [Full Text] [Related]
12. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of graft-versus-host disease following bowel transplantation with recipient specific leukocyte transfusion.
Xiao F; Foster PF; Sankary HN; Kociss K; Williams JW
Transplant Proc; 1992 Jun; 24(3):1192-3. PubMed ID: 1604582
[No Abstract] [Full Text] [Related]
14. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
Williams FH; Thiele DL
Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
[TBL] [Abstract][Full Text] [Related]
15. Risk of donor lymphocyte infusions following allogeneic bone marrow transplantation.
van Bekkum DW; Kinwel-Bohré EP
Exp Hematol; 1997 Jun; 25(6):478-80. PubMed ID: 9197324
[TBL] [Abstract][Full Text] [Related]
16. Immune tolerance to self-MHC class II antigens after bone marrow transplantation.
Hess A; Horwitz L; Thoburn C
Transplant Proc; 1999; 31(1-2):688-9. PubMed ID: 10083297
[No Abstract] [Full Text] [Related]
17. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Champlin R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
[No Abstract] [Full Text] [Related]
18. Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
Schumm M; Kolb HJ; Hahn J; Beisser K; Rieber P; Günther W; Büttner M; Wilmanns W; Thierfelder S
Prog Clin Biol Res; 1992; 377():419-25. PubMed ID: 1438440
[No Abstract] [Full Text] [Related]
19. Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation.
Gassmann W; von Kolszynski M; Wottge HU; Müller-Ruchholtz W
Transplant Proc; 1987 Feb; 19(1 Pt 3):2687-8. PubMed ID: 3079091
[No Abstract] [Full Text] [Related]
20. Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells.
Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
Transplant Proc; 1993 Feb; 25(1 Pt 1):475-6. PubMed ID: 8438384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
